|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidents for Chlamydia pneumoniae infection: The azithromycin in coronary artery disease elimination of myocardial infection with chlamydia (ACADEMIC) study显示文摘 | Muhlstein J B Carlquist J | 1999 | Circulation1999，99，： | 1 |
| 2 | Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective study显示文摘 | Carlquist J F Home B D Muhlestein J B | 2006 | J Thromb Thrombolysis2006，22，3： | 1 |
| 3 | Multiple-polymorphism associations of7matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease显示文摘 | Horne B D Camp N J Carlquist J F | 2007 | Am Heart J2007，154，4： | 1 |
| 4 | Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for chlamydia pneumoniae: the azithronmcin in coronary artery disase: elinination of myocardial infection with chlamydia study显示文摘 | Anderson JL Muhlestein JB Carlquist J | 1999 | Circulation1999，99，12： | 1 |
| 5 | Multiple poly morphis mass ociations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinasegenes with myocardial infarction and anglo graphic coronary artery disease显示文摘 | Home B D Camp N J Carlquist J F | 2007 | American Heart Journal2007，154，4： | 1 |
| 6 | Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study显示文摘 | Muhlestein J B Anderson J L Carlquist J F | 2000 | Circulation2000，102，15： | 1 |
| 7 | A common vari- ant of the AMPD1 gene predicts improved survival in patients with isehemic left ventricular dysfunction显示文摘 | Yazaki Y Muhlestein J B Carlquist J F | 2004 | Journal of Cardiac Failure2004，10，4： | 1 |
| 8 | Evaluation of C-reactive protein,an inflammation marker,and infectious serology as risk factors for coronary artery disease and myocardial infarction显示文摘 | ANDERSON J L CARLQUIST J F MUHLESTEIN J B | 1998 | J Am Coll Cardiol1998，32，： | 1 |
| 9 | The cholesteryl ester transfer protenin Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease 显示文摘 | CARLQUIST J F MUHLESTEIN J B HORNE B D | 2003 | Am Hear J2003，146，6： | 1 |
| 10 | Evaluation of C reactive protein, an inflammatory marker, and infection serology as risk factors for coronary artery disease and myocardial infarction 显示文摘 | ANDERSON J L CARLQUIST J F MUHLESTEIN J B | 1998 | J Am Coil CardioI1998，32，1： | 1 |
| 11 | Isolation of a porcine in-testinal peptide with c-temlinal somatostatin 显示文摘 | Pradayrol L Chayvialle J A Carlquist M | 1978 | Biochemical and Bio-physical Research Communications1978，85，2： | 1 |
| 12 | The cholesteryl ester transfer protein TaqlB gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease 显示文摘 | Carlquist J F Muhlestein J B Home B D | 2003 | American Heart Journal2003，146，6： | 1 |
| 13 | Deficient natural killer cell activity in patients with idiopathic dilated cardiomyopathy显示文摘 | Anderson J Carlquist JF Hammond EH | 1982 | Lancet1982，2，： | 1 |
| 14 | Serum u- ric acid independently predicts mortality in patients with sig-nificant, angiographically defined coronary disease 显示文摘 | Madsen T E Muhlestein J B Carlquist J F | 2005 | Am J Nephrol2005，25，1： | 1 |
| 15 | Evaluation of C-reactive protein, an inflammatory marker, and infection serology as risk factors for coronary artery disease and myocardial infarction显示文摘 | ANDERSON J L CARLQUIST J F MUHLESTEIN J B | 1998 | J Am Coll Cardiol1998，32，1： | 1 |
| 16 | Evaluation of C- reactive protein, an inflammation and myocardial infectins serology as risk factors for coronary artery disease and myocardial infarcfion显示文摘 | Anderson J L Carlquist J F Muhlestein J B | 1998 | J Am Coil Cardiol1998，32，： | 1 |
| 17 | Toll-like recep- tor 4 gene Asp299Gly polymorphism is associated with reductions in vascular inflammation, angiographic coronary artery disease, and clinical diabetes显示文摘 | Kolek M J Carlquist J F Muhlestein J B | 2004 | Am Heart J2004，148，6： | 1 |
| 18 | NADH- dependent biosensor in Saccharomyces cerevisiae: principle and validation at the single cell level显示文摘 | Knudsen J D Carlquist M Gorwa G M | 2014 | AMB Express2014，4，1： | 1 |
| 19 | CytomegalovirusSeropositivity and C-reactive protein have independent and combined predictive value for mortality in patient with angiographically demonstrated coronary artery disease显示文摘 | MUHLESTEIN J B HORNE B D CARLQUIST J F | 2000 | Circulation2000，102，： | 1 |
| 20 | A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease显示文摘 | Norman J L Habashi J Carlquist J F | 2000 | J Am Coll Cardiol2000，36，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员